1. Home
  2. LABT vs IZM Comparison

LABT vs IZM Comparison

Compare LABT & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

N/A

Current Price

$2.56

Market Cap

4.6M

Sector

Health Care

ML Signal

N/A

Logo ICZOOM Group Inc.

IZM

ICZOOM Group Inc.

HOLD

Current Price

$0.30

Market Cap

4.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LABT
IZM
Founded
N/A
2011
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Video Chains
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
4.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LABT
IZM
Price
$2.56
$0.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
276.0K
436.3K
Earning Date
N/A
10-24-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$10.39
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$0.26
52 Week High
$4.72
$2.74

Technical Indicators

Market Signals
Indicator
LABT
IZM
Relative Strength Index (RSI) 31.54 41.50
Support Level $2.10 N/A
Resistance Level N/A $0.47
Average True Range (ATR) 0.61 0.04
MACD -0.10 -0.01
Stochastic Oscillator 19.85 22.29

Price Performance

Historical Comparison
LABT
IZM

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

About IZM ICZOOM Group Inc.

ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.

Share on Social Networks: